NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects.

Author(s): Haus E, Cusulos M, Sackett-Lundeen L, Swoyer J

Publication: Chronobiol Int, 1990, Vol. 7, Page 203-16

PubMed ID: 2125246 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of circadian rhythm on hematology analytes.

Conclusion of Paper

Circadian rhythm was found to affect platelet aggregation in response to adenosine diphosphate (ADP) and adrenalin, platelet adhesiveness, prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen, Factor VIII activity, and alpha-1-antitrypsin antigen. None of the changes observed due to time of biospecimen collection were large enough to be of clinical significance, but they were generally suggestive of a state of hypercoagulability during the morning. No significant trends could be determined based on the time of biospecimen collection for the levels of plasminogen, alpha-2-macroglobulin, antithrombin III antigen, Factor V, or fibrinogen degradation products due to high degrees of variability.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of circadian rhythm on coagulation parameters, platelet adhesion and aggregation, and other hematology analytes. Complete blood counts were determined, and plasma cortisol was measured as reference functions. Blood was collected from subjects in the recumbent position at all time points, but during normal waking hours, subjects were ambulatory until 30 min prior to each blood draw.

    Summary of Findings:

    Circadian rhythm was found to affect platelet aggregation in response to ADP and adrenalin, platelet adhesiveness, PT, APTT, TT, fibrinogen, Factor VIII activity, and alpha-1-antitrypsin antigen. None of the changes observed due to time of biospecimen collection were large enough to be of clinical significance, but they were generally suggestive of a state of hypercoagulability during the morning. However, maximal aggregation, in response to ADP or adrenalin, was achieved in platelet rich plasma from specimens collected at 12:00 am. No significant trends could be determined based on the time of biospecimen collection for the levels of plasminogen, alpha-2-macroglobulin, antithrombin III antigen, Factor V, or fibrinogen degradation products due to high degrees of variability.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Cell count/volume Hematology/ auto analyzer
    Protein Hematology/ auto analyzer
    Morphology Hematology/ auto analyzer
    Cell count/volume Light microscopy
    Cell count/volume Coulter counter
    Steroid Radioimmunoassay
    Glycoprotein Hematology/ auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Time of biospecimen collection 8:00 am
    12:00 pm
    4:00 pm
    8:00 pm
    12:00 am
    4:00 am

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...